The San Diego biotech aims to initiate human trials for its AI-designed brain-penetrant KIF18A inhibitor.
Live Poll
Will AI-driven platforms significantly shorten the development time for new cancer medications?
The company plans to fund clinical trials for its pipeline using proceeds from its public market entry.
Live Poll
Do you trust AI-powered tools to help you navigate your legal matters more effectively?
The platform automates client communication and assists attorney strategy using data from 130,000 past cases.
Live Poll
Do you support the deployment of self-driving robotaxis in your city?
Despite a unanimous council vote against autonomous vehicles, the city lacks the legal authority to ban the services.
